Playbill streams Broadway's 'Bandstand' by CCM Acting alumnus

Richard Oberacker's Tony Award-winning musical features the work of multiple CCM alumni

Playbill streams the 2017 Broadway musical Bandstand, written by UC College-Conservatory of Music alumnus Richard Oberacker (BFA Acting, ’93) and Robert Taylor, through April 17, 2020. The Tony Award-winning musical tells the story of World War II veteran Donny Novitski, who forms a band with fellow veterans and enters a national contest to become America’s newest musical sensation.

Two men smile under the lights of Broadway's "Bandstand" musical marquee.

Richard Oberacker with CCM Acting Professor Richard Hess at a preview performance of “Bandstand” on Broadway.

The first Playbill Playback, a new series in which old and recent favorite musicals can be streamed on Playbill.com, Bandstand is available for streaming online through April 17. A portion of the proceeds raised with the stream will go to The Actors Fund.

The Bandstand stream will also feature an interview with co-stars Laura Osnes, Corey Cott and Beth Leavel as well as director-choreographer Andy Blankenbuehler and co-creators Oberacker and Taylor.

In addition to Oberacker, alumni from across CCM are involved in this award-winning musical. Geoff Packard (BFA Musical Theatre, ’04) plays Wayne Wright, a trombonist in the veteran band; Max Clayton (BFA Musical Theatre, ’14) is in the ensemble; Greg Anthony Rassen (MM Orchestral Conducting, ’03) is the co-orchestrator, music supervisor and music arranger; and David Kreppel (BFA Musical Theatre, ’92) is the vocal music arranger.

Bandstand was the first theatrical production in history to be certified authentic by Got Your 6, an organization that advocates for authentic portrayal of the military across entertainment.

Learn more about the Bandstand stream on Playbill.


Featured image at the top: Playbill Playback series graphic. Photo/Playbill.com

Related Stories

1

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.